Cleveland Clinic opens its London hospital

The Cleveland Clinic has opened the doors to its new hospital in central London, the latest international location for the healthcare system’s growing global footprint.

Cleveland Clinic London offers a global network of doctors and specialists to deliver best practice and the clinic’s core values, according to a press release. Its physician-led model of care is based on research and education.

The 184-bed hospital, which opened on Tuesday March 29, is the second in the health system in London, after the Cleveland Clinic Portland Place Outpatient Centre. The six-story, 28,000 square foot outpatient facility opened in September 2021 at Portland Place in the Harley Street Medical Area, where outpatient services will continue to be offered.

The new hospital, located at 33 Grosvenor Place, will offer a full range of medical subspecialties, with an emphasis on heart and vascular disease, digestive, neuroscience and orthopaedics.

Supported by an acute admissions unit and intensive care specialists 24/7, Cleveland Clinic London can care for a complex patient population, according to the statement, which notes that the hospital will also offer comprehensive imaging, laboratory and interventional radiology services.

The eight-story facility includes 29 intensive care beds and eight operating theaters, a 41-bed neurological rehabilitation ward and a staff of around 1,150 caregivers, according to the statement.

“For more than 100 years, The Cleveland Clinic has been at the forefront of medical innovation and specialty healthcare,” said Dr. Tom Mihaljevic, president and CEO of the Cleveland Clinic, in a statement provided. “We believe that touching more lives is our ethical imperative. With the opening of Cleveland Clinic London, we are extending our unique model of care to more patients than ever before.”

Download the Modern Healthcare app to stay informed when industry news is breaking.

Cleveland Clinic London is equipped with advanced medical and surgical technologies, including, according to the release: innovative laser and robotic surgery capabilities; minimally invasive procedures, such as transcatheter aortic valve implantation (TAVI), in which the Clinic was one of the first pioneers; intraoperative imaging for brain and spinal cord disorders, a leading tool in the prevention of reoperations; and a 41-bed neuro-rehabilitation suite with state-of-the-art robotic equipment.

Cleveland Clinic London is also the first UK hospital to use advanced technology such as pharmacy barcoding and robotic medication administration tracking, according to the statement, which notes that this provides an additional level of security in drug delivery.

Read more: In the high-stakes world of pathology, the Cleveland Clinic turns to AI

“We are delighted to bring our unique model of care to the UK, combining London’s world-renowned physicians and research with Cleveland Clinic’s 100-year history of technological advancements and clinical expertise,” said said Dr Brian Donley, CEO of Cleveland Clinic London. , in a statement provided. “We will provide patients with an unparalleled experience and the highest quality care.”

Since 2004, the Clinic has required all clinical specialties to collect and publish comprehensive data annually. In 2008, it began disclosing its clinicians’ relationships with industry, and in 2015, the clinic began posting patient ratings and feedback on the care they receive, according to the release. Similarly, Cleveland Clinic London will report data and results to major UK national registries and publish detailed information about its treatment outcomes to help patients make informed decisions about their care options.

The Cleveland Clinic London welcomes bookings from eligible members covered by all major national and international insurers, self-paid and embassy-sponsored patients, according to the statement.

This story first appeared in our sister publication, Crain’s Cleveland Business.

About Hector Hedgepeth

Check Also

New study challenges widely held beliefs about Alzheimer’s disease

A new study challenges the dogma behind drug trials for Alzheimer’s disease. The study found …